Shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) have been assigned an average rating of “Hold” from the twenty-one brokerages that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, nine have issued a hold recommendation and eleven have assigned a buy recommendation to the company. The average 1 year price objective among brokerages that have issued a report on the stock in the last year is $15.13.
Several research analysts recently issued reports on the company. Citigroup Inc. lifted their price objective on Allscripts Healthcare Solutions from $13.00 to $14.00 and gave the stock a “neutral” rating in a research report on Monday, August 7th. Cantor Fitzgerald restated a “buy” rating and set a $17.00 price objective (up from $15.00) on shares of Allscripts Healthcare Solutions in a research report on Monday, August 14th. Royal Bank Of Canada assumed coverage on Allscripts Healthcare Solutions in a research report on Tuesday, September 19th. They set an “outperform” rating and a $17.00 price objective for the company. Robert W. Baird restated a “buy” rating and set a $16.00 price objective on shares of Allscripts Healthcare Solutions in a research report on Tuesday, October 17th. Finally, Zacks Investment Research upgraded Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a research report on Wednesday, August 9th.
In other news, CEO Paul Black sold 15,000 shares of the business’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $13.52, for a total transaction of $202,800.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Brian Farley sold 5,000 shares of the business’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $13.52, for a total transaction of $67,600.00. Following the sale, the executive vice president now directly owns 196,607 shares of the company’s stock, valued at $2,658,126.64. The disclosure for this sale can be found here. Insiders have sold a total of 35,000 shares of company stock valued at $473,800 over the last three months. Corporate insiders own 0.75% of the company’s stock.
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Neuberger Berman Group LLC grew its stake in shares of Allscripts Healthcare Solutions by 5.5% during the 3rd quarter. Neuberger Berman Group LLC now owns 3,676,088 shares of the software maker’s stock valued at $52,311,000 after buying an additional 190,158 shares during the period. California Public Employees Retirement System boosted its position in Allscripts Healthcare Solutions by 5.6% during the 3rd quarter. California Public Employees Retirement System now owns 506,028 shares of the software maker’s stock worth $7,201,000 after purchasing an additional 26,928 shares during the period. Janney Montgomery Scott LLC purchased a new stake in Allscripts Healthcare Solutions during the 3rd quarter worth $710,000. Janney Capital Management LLC boosted its position in Allscripts Healthcare Solutions by 239.8% during the 3rd quarter. Janney Capital Management LLC now owns 997,009 shares of the software maker’s stock worth $14,187,000 after purchasing an additional 703,598 shares during the period. Finally, Cubist Systematic Strategies LLC boosted its position in Allscripts Healthcare Solutions by 67,189.1% during the 3rd quarter. Cubist Systematic Strategies LLC now owns 30,953 shares of the software maker’s stock worth $440,000 after purchasing an additional 30,907 shares during the period.
Shares of Allscripts Healthcare Solutions (MDRX) traded up $0.38 during trading on Monday, hitting $13.14. The company had a trading volume of 1,690,906 shares, compared to its average volume of 2,346,123. The company has a debt-to-equity ratio of 1.20, a current ratio of 0.98 and a quick ratio of 0.98. Allscripts Healthcare Solutions has a 1 year low of $10.19 and a 1 year high of $14.45. The firm has a market cap of $2,370.00, a P/E ratio of 29.63, a P/E/G ratio of 2.27 and a beta of 1.34.
TRADEMARK VIOLATION NOTICE: This piece was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.dispatchtribunal.com/2017/12/02/allscripts-healthcare-solutions-inc-mdrx-receives-15-13-consensus-target-price-from-brokerages.html.
About Allscripts Healthcare Solutions
Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.
Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.